Soluble mesothelin (SM) and megakaryocyte potentiating factor (MPF) are serum biomarkers of mesothelioma. This study aims to examine the longitudinal behavior of SM and MPF in controls to gain insight in the optimal use of these biomarkers in screening.status: publishe
Purpose: High levels of serum-soluble mesothelin family proteins (SMRP) have been found to be associ...
Background: Soluble mesothelin (SM) and megakaryocyte potentiating factor (MPF) are serum biomarkers...
Objectives: Asbestos-related diseases (ARDs) have increased globally over the decades, causing an ec...
Introduction: Soluble mesothelin (SM) and megakaryocyte potentiating factor (MPF) are serum biomarke...
IntroductionSoluble mesothelin (SM) and megakaryocyte potentiating factor (MPF) are serum biomarkers...
Abstract: Rationale: Soluble mesothelin (SM) is currently the reference serum biomarker of malignant...
Rationale: Soluble mesothelin (SM) is currently the reference serum biomarker of malignant pleural m...
Soluble mesothelin-related protein (SMRP) in serum is potentially a sensitive marker of malignant me...
The MSLN gene products, soluble mesothelin and megakaryocyte potentiating factor (MPF), are being in...
Copyright © 2013 Jenette Creaney et al.This is an open access article distributed under the Creative...
IntroductionThere is increasing interest in identifying a blood-based marker for the asbestos-relate...
Exposure to asbestos is the main cause of malignant pleural mesothelioma (MPM), a highly aggressive ...
Introduction: Soluble mesothelin (SM), megakaryocyte potentiating factor (MPF), and osteopontin (OPN...
Asbestos exposure is associated with increased risk of several diseases, including malignant mesothe...
IntroductionSoluble mesothelin (SM), megakaryocyte potentiating factor (MPF), and osteopontin (OPN) ...
Purpose: High levels of serum-soluble mesothelin family proteins (SMRP) have been found to be associ...
Background: Soluble mesothelin (SM) and megakaryocyte potentiating factor (MPF) are serum biomarkers...
Objectives: Asbestos-related diseases (ARDs) have increased globally over the decades, causing an ec...
Introduction: Soluble mesothelin (SM) and megakaryocyte potentiating factor (MPF) are serum biomarke...
IntroductionSoluble mesothelin (SM) and megakaryocyte potentiating factor (MPF) are serum biomarkers...
Abstract: Rationale: Soluble mesothelin (SM) is currently the reference serum biomarker of malignant...
Rationale: Soluble mesothelin (SM) is currently the reference serum biomarker of malignant pleural m...
Soluble mesothelin-related protein (SMRP) in serum is potentially a sensitive marker of malignant me...
The MSLN gene products, soluble mesothelin and megakaryocyte potentiating factor (MPF), are being in...
Copyright © 2013 Jenette Creaney et al.This is an open access article distributed under the Creative...
IntroductionThere is increasing interest in identifying a blood-based marker for the asbestos-relate...
Exposure to asbestos is the main cause of malignant pleural mesothelioma (MPM), a highly aggressive ...
Introduction: Soluble mesothelin (SM), megakaryocyte potentiating factor (MPF), and osteopontin (OPN...
Asbestos exposure is associated with increased risk of several diseases, including malignant mesothe...
IntroductionSoluble mesothelin (SM), megakaryocyte potentiating factor (MPF), and osteopontin (OPN) ...
Purpose: High levels of serum-soluble mesothelin family proteins (SMRP) have been found to be associ...
Background: Soluble mesothelin (SM) and megakaryocyte potentiating factor (MPF) are serum biomarkers...
Objectives: Asbestos-related diseases (ARDs) have increased globally over the decades, causing an ec...